DRAFT- FOR INTERNAL USE ONLY / DO NOT DISTRIBUTE
The Surgeon Who Refused to Let Healing End in the Operating Room
A Visionary Champion of Exercise Oncology, Patient Empowerment, and
Survivorship Care
By: Lennard M. Goetze, Ed.D - Sr. Publisher of the AngioMedical Press and ICRS NEWS (Integrative Cancer Resource Society)
For nearly five decades, Dr. Jay Harness built his life around the operating room. As a surgical oncologist specializing in breast cancer, he helped guide thousands of patients through one of the most frightening moments of their lives. He removed tumors, navigated complex treatment pathways, and bore witness to both triumph and loss. But after 47 years of clinical practice, Dr. Harness reached a profound realization: surgery and medicine alone were not enough to fully serve the long-term needs of people living with and beyond cancer.
Instead of stepping quietly into retirement, Dr. Harness pivoted into what would become the most unexpected—and arguably most impactful—chapter of his career: Exercise Oncology. “I was thunderstruck by the science,” Dr. Harness says. “For over 35 years, there were thousands of clinical trials and tens of thousands of publications showing how exercise improves survival, reduces recurrence, and helps patients tolerate treatment. And yet, most physicians had never been taught this.”
This moment of discovery became a call to action. Dr. Harness realized that a powerful body of evidence existed—but it was trapped inside academic silos. Researchers in exercise physiology and kinesiology had been building a mountain of data, while oncologists and surgeons largely remained unaware of its implications. The result? Patients were missing out on one of the most accessible, evidence-backed tools available to support recovery, resilience, and long-term survival.
“For decades, the scientists were essentially talking to themselves,” he explains. “There was very little crossover into everyday oncology care. That gap is what I’m trying to fill.”
From Scalpel to
Systems Change
Dr. Harness’s career shift was not about abandoning medicine—it was about expanding it. He recognized that true healing does not end when a tumor is removed or chemotherapy concludes. Cancer changes the body, the mind, and the identity of a person. Survivorship is not simply about being alive—it is about restoring function, confidence, and quality of life.
Through his leadership in CancerFitness.org, Dr. Harness has created an educational hub designed for both patients and clinicians. The platform translates complex science into practical guidance on how movement can support patients before treatment (prehabilitation), during therapy, and throughout long-term survivorship. “Exercise oncology should be a continuum of care,” he says. “It’s not just something you do after treatment. It starts before diagnosis, continues during therapy, and becomes part of long-term survivorship.”
The science supports him. Patients who were physically active prior to diagnosis show improved survival outcomes. Those who engage in moderate exercise during treatment often tolerate chemotherapy better and report less fatigue, anxiety, and depression. Long-term survivors who remain active experience significantly lower all-cause mortality.
“This isn’t about running marathons,” Dr. Harness emphasizes. “We’re talking about moderate activity—brisk walking, cycling, resistance training. Small, consistent movement can change biology.”
The Biology of
Movement
What excites Dr. Harness most is not only what exercise does—but how it does it. “Every time muscles contract, they release signaling molecules that reduce inflammation and influence cancer-related pathways,” he explains. “Exercise stimulates mitochondrial function, improves immune response, enhances blood flow, and supports neurological health.”
This emerging understanding of exercise as a biological intervention reframes movement as more than lifestyle advice—it becomes a clinical tool. In this view, walking is not simply “good for you”; it is a molecular signal that tells the body how to heal. “We’re finally starting to understand that movement is medicine at the cellular level,” he says. “That changes how we should think about recovery.”
Education: The
Missing Link in Cancer Care
Despite overwhelming evidence, adoption remains slow. Dr. Harness identifies physician education as the single greatest barrier. “The vast majority of my colleagues were never taught this science in medical school or residency,” he says. “You can’t refer patients to something you don’t know exists.”
To change this, Dr. Harness lectures nationally
and internationally, including at major breast surgery and oncology
conferences. He works to normalize exercise oncology as part of standard
supportive care—not as an optional add-on, but as a core component of treatment
strategy. “If
Building Infrastructure for Survivors
Through collaborations with organizations like Maple Tree Cancer Alliance, Dr. Harness advocates for certified exercise oncology specialists embedded within cancer centers and community fitness programs. His goal is not to tell patients to “exercise more,” but to create structured, supervised pathways that safely integrate movement into care plans.
“Brochure therapy doesn’t work,” he says bluntly. “Handing patients a pamphlet and hoping they figure it out is not healthcare. Referrals to structured programs work.” This approach reflects Dr. Harness’s systems-level thinking: education alone is not enough. Infrastructure matters. Access matters. Training matters.
A Vision for 2026 and Beyond
At its heart, Dr. Harness’s work is not about fitness—it is about dignity. It is about restoring agency to patients who often feel their bodies have betrayed them. It is about reminding people that movement is not a punishment or a chore—it is a form of biological hope.
“Cancer takes a lot away from people,” he reflects. “Exercise gives them something back—a sense of control, strength, and forward momentum.”
The Legacy of a Modern Healer
Dr. Jay Harness represents a new archetype in oncology: the surgeon who refuses to let care stop at the operating table, the educator who bridges science and humanity, and the visionary who understands that healing is not only about removing disease—but restoring life. “If we truly care about outcomes,” he says, “we have to care about how people live after treatment. Survival is the starting line, not the finish.” In a healthcare system still catching up to the science of survivorship, Dr. Harness stands as both a catalyst and a compass—pointing toward a future where movement is no longer an afterthought, but a cornerstone of cancer care.
PART 2
Active
Surveillance After Cancer: Restoring the Terrain — Imaging the Body Back to
Strength
By Dr. Robert L. Bard, MD,DABR, FAIUM, FASLMS
(Cancer Radiologist | Post-Treatment Active Surveillance Specialist)
What I monitor through ultrasound, Doppler imaging, elastography, thermography, and optical vascular scanning is not just the absence of disease—but the condition of the terrain in which healing must continue. Fibrosis, vascular compromise, lymphatic congestion, mitochondrial fatigue, neuropathy, and inflammatory burden often persist long after treatment ends. In many patients, the question is no longer “Is the cancer visible?” but rather, “Is the body resilient enough to prevent its return?”
This is where restorative medicine, rehabilitation, and exercise oncology intersect with diagnostic imaging.
From my clinical vantage point, movement is not a lifestyle suggestion—it is a biological signal. The tissues I evaluate change when circulation improves. Microvascular flow shifts. Oxygenation patterns normalize. Fibrotic tissue softens. Neural conductivity responds. These are measurable phenomena. When patients engage in consistent, moderate physical activity as part of their recovery, I often observe functional improvements in tissue health that imaging can corroborate over time.
In this context, exercise becomes more than physical rehabilitation. It becomes an immune-supportive intervention. Movement lowers baseline cortisol over time, improves mood through neurochemical regulation, and enhances mitochondrial function. These changes translate into improved immune signaling, better treatment tolerance, and, critically, improved psychological stamina. Patients who move tend to endure treatment better—not just physically, but emotionally. And emotional endurance matters. Hope, agency, and participation in one’s own recovery are not abstract ideals; they are biological contributors to immune competence.
From the imaging perspective, active surveillance is not passive observation. It is an opportunity to track recovery. Safe, repeatable imaging allows us to assess vascular response, tissue remodeling, inflammatory patterns, and structural recovery over time. When movement is integrated into survivorship care, we can correlate functional change with imaging evidence—providing patients with visual proof that their efforts are reshaping their internal environment.
Cancer treatment is often described as a war. But recovery is closer to reconstruction. It requires restoring circulation, rebuilding metabolic resilience, calming inflammation, and re-establishing neurological balance. Exercise oncology, when guided responsibly, supports each of these domains. Imaging allows us to verify that restoration is occurring—not as theory, but as measurable change within the body.
Active surveillance should not only watch for recurrence. It should actively support recovery. When diagnostics, movement, and emotional resilience align, the body is no longer merely surviving cancer—it is reclaiming its capacity to defend itself.
In this emerging model of post-cancer care, we are no longer just looking for what remains of disease. We are imaging the return of strength.
